drugset / Press release
ESMO 2025 Poster Presentation: A Phase 1/2 Study of JK06, a 5T4-Targeted Antibody Drug Conjugate (ADC), in Patients with Unresectable Locally Advanced or Metastatic Cancer
2025-10-13 · Salubris Biotherapeutics Inc · original salubrisbio.com ↗
Click here to view PDF
The release as fetched from its publisher. salubrisbio.com ↗